Astria Therapeutics, Inc. (ATXS)
NASDAQ: ATXS · Real-Time Price · USD
5.61
+0.17 (3.12%)
Jun 27, 2025, 12:21 PM - Market open
Astria Therapeutics Employees
Astria Therapeutics had 78 employees as of December 31, 2024. The number of employees increased by 19 or 32.20% compared to the previous year.
Employees
78
Change (1Y)
19
Growth (1Y)
32.20%
Revenue / Employee
n/a
Profits / Employee
-$1,385,141
Market Cap
316.60M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ATXS News
- 9 days ago - Astria Therapeutics to Participate in Upcoming Oppenheimer Innovators in Immunology & Inflammation Summit - Business Wire
- 14 days ago - Astria Therapeutics Announces Positive Initial Results from the ALPHA-SOLAR Long-Term Open-Label Trial of Navenibart in Hereditary Angioedema Patients at the European Academy of Allergy and Clinical Immunology Annual Congress - Business Wire
- 21 days ago - Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Annual Congress - Business Wire
- 23 days ago - Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 4 weeks ago - Astria Therapeutics to Present at Upcoming Jefferies Global Healthcare Conference - Business Wire
- 5 weeks ago - Astria Therapeutics to Present at Upcoming C1 Inhibitor Deficiency and Angioedema Workshop - Business Wire
- 5 weeks ago - Astria Therapeutics to Present at Upcoming Eastern Allergy Conference - Business Wire
- 6 weeks ago - Astria Therapeutics Reports First Quarter 2025 Financial Results and Provides a Corporate Update - Business Wire